Viewing Study NCT04912869


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-05-05 @ 6:59 AM
Study NCT ID: NCT04912869
Status: COMPLETED
Last Update Posted: 2025-08-26
First Post: 2021-06-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD).
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vaso-occlusive episodes View
None Pain crisis View